Continuous Positive Airway Pressure Treatment, Glycemia, and Diabetes Risk in Obstructive Sleep Apnea and Comorbid Cardiovascular Disease.
Kelly A LofflerEmma HeeleyRuth FreedRosie MengLia R BittencourtCarolina C Gonzaga CarvalhoRui ChenMichael HlavacZhihong LiuGeraldo Lorenzi-FilhoYuanming LuoNigel McArdleSutapa MukherjeeHooi Shan YapXilong ZhangLyle J PalmerCraig S AndersonR Doug McEvoyLuciano F Dragernull nullPublished in: Diabetes care (2020)
Among patients with established CVD and OSA, we found no evidence that CPAP therapy over several years affects glycemic control in those with diabetes or prediabetes or diabetes risk over standard-of-care treatment. The potential differential effect according to sex deserves further investigation.
Keyphrases
- obstructive sleep apnea
- glycemic control
- positive airway pressure
- cardiovascular disease
- type diabetes
- sleep apnea
- blood glucose
- healthcare
- weight loss
- insulin resistance
- palliative care
- quality improvement
- coronary artery disease
- cardiovascular events
- climate change
- pain management
- adipose tissue
- chemotherapy induced